| ABOUT BAYBIOGET INVOLVEDEVENT CENTER
MEMBER CENTERINFORMATION CENTERMEDIA CENTERCAREER CENTER |
Advancements in Oncology: Beyond Radiation Sponsored by:
![]() With Support From:
Over 1.4 million new cases of cancer were reported in the United States in 2008 alone. Cancer, which causes about 13 percent of deaths each year worldwide, can be treated and some can be cured depending on the specific type, location and stage of the tumor. In recent years, there has been significant progress in the development of targeted therapies for various tumor types including small-molecule drugs, apoptosis-inducing drugs, and monoclonal antibodies. In essence, these treatments eliminate the need for chemotherapy and radiation therapy and promise to offer a more tailored approach to treatment, harming fewer normal cells, reducing side effects, and improving patients’ quality of life. In this session, leading Northern California life science companies will discuss their product development efforts, therapies currently on the market, and the potential impact they have on the treatment of cancer. Panel Moderator:Emily Hua Vice President, Brand Management Practice, Campbell Alliance Panel Speakers: Steven Benner Senior Vice President and CMO, OncoMed Pharmaceuticals John Curd, MD President and CMO, Threshold Pharmaceuticals David Kirn, MD CEO, Jennerex Biotherapeutics
Registrations: If you are an employee of a Partner or Sponsor company, please contact Program Director, Misha Tsirulnikov to obtain your complimentary registration. On-line reservations: CLICK HERE Reservations by mail or fax: CLICK HERE
Is your company a member? Click here to check. See how your company can save money by becoming a BayBio member! |